A new U.K. study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) ...

Medically reviewed by Jay N. Yepuri, MD Biliary colic is abdominal pain that develops due to a blockage in the bile ducts, ...

If the subcutaneous delivery method gains approval, an advantage daratumumab holds over isatuximab would be removed.

Next Health, the world's most advanced brand of health optimization and longevity centers, is making its Tennessee debut with its first Nashville-area location on Monday, January 20 in The Gulch, ...

Sanofi SA (NASDAQ:SNY) released results from the IRAKLIA phase 3 study evaluating the non-inferiority of Sarclisa (isatuximab ...

HOPE Therapeuticstm, Inc., ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx Pharmaceuticals, Inc. ("NRx", and collectively with HOPE, the "Company") , today ...

SPHERE has brought together London’s most luxurious wellness clubs with no membership needed. All flexible and offering the ...

Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma: Paris Friday, January 10, 2025, 15:00 Hrs [IST] Res ...

Traditionally, engineers spent months developing healthcare solutions for clinicians, often missing the mark on practical needs. The Hippocratic AI Agent App Store seeks to turn this paradigm on its ...

GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

PBFT02 demonstrated durable, elevated CSF PGRN levels and early evidence of reduction in plasma <a target=_blank href= ...